Feedback / Questions
CTA311 - Nanjing Bioheng Biotech, Wuhan Union Hospital
https://www.globenewswire.com/news-release/2025/12/08/3202010/0/en/Imviva-Biotech-Presents-Validating-Data-for-CAR-T-Cell-Therapies-CTD402-and-CTA311-in-Five-Presentations-at-the-67th-American-Society-of-Hematology-Annual-Meeting.html
Dec 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next